Dr. Sharon Rosenzweig-Lipson is the chief scientific officer for Life Biosciences, Inc. She has held leadership positions in both big pharma and small biotechnology companies over the course of her 30+ year career. She has a proven track record of advancing programs from the early exploratory phase through to Phase 2B. Her career in big pharma includes American Cyanamid, American Home Products, Wyeth, and Pfizer, where she led a team to a successful Phase 2 proof of concept study. As VP of R&D for AgeneBio, Sharon led the clinical development of its lead asset through Phase 2B clinical trials as well as the company’s preclinical discovery program. Sharon is globally recognized for her top scientific and strategic leadership, having led global translational alliances and has a strong publication and patent record. A key focus for Sharon is building high-quality, integrated, cross-functional teams utilizing both internal and external talent to deliver programs in a timely manner employing evidence-based decision making. She earned her BA in biological basis of behavior from the University of Pennsylvania and her PhD in psychology (behavioral neuroscience) from Harvard University.